Age at baseline most important factor affecting BPH progression in treatedpatients


Chicago-A higher age at baseline predicted increased rate of progressionin all three treatment arms of the Medical Therapy of Prostate Symptoms(MTOPS) trial, according to a secondary analysis of data presented at theAUA meeting yesterday.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.